Sphingosine kinase and uses thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- MEDVET SCI
- Publication Date
- 2003-08-13
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
field of invention
[0001] The present invention relates generally to methods of modulating cell growth, and more particularly, the present invention relates to methods of down-regulating neoplastic cell growth. The present invention is particularly useful in the therapeutic and / or prophylactic treatment of cancers such as but not limited to solid cancers such as colon, stomach, lung, brain, bone, esophagus, pancreas, breast, ovary or uterus . Background of the invention
[0002] A bibliography of publications cited by the authors throughout this specification is collected at the end of this specification.
[0003] Reference to any prior art in this specification is not, and should not be taken as, an acknowledgment or any form of suggestion that such prior art forms part of the common general knowledge in Australia.
[0004] Sphingosine kinases are key regulatory enzymes in diverse cellular responses. Sphingosine-1-phosphate is known to be an important second messenger in...